Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Brilliant Blue G (AC153)
Cat.#: ASSD-153
Specifications
Description Brilliant Blue G is a type of non-competitive P2X7 antagonist (IC50 values are 10 and 200 nM at rat and human P2X7 respectively). The compound displays neuroprotective and anti-inflammatory properties. It is also a protein-binding dye, causing a color change from red to blue. Synonyms Acid blue 90; Coomassie Brilliant Blue G; NSC 328382; CBBG Size 1g Chemical Name Coomassie Brilliant Blue G (CBBG) Molecule Weight 854.02 Molecular formula C47H48N3NaO7S2 CAS Number 6104-58-1 PubChem identifier 6324599 Solubility Soluble in water (40mg/ml, at 20°C) or methanol Storage RT Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-224 Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) 10 mL inquiry ASSD-132 Congo Red (AC132) 100 mg, 1g inquiry ASSD-163 Ponceau S sodium salt (AC163) 25 g inquiry ASSD-220 Nitrofluorescein, Isomer 2 (AC220) 1 g inquiry ASSD-156 Crystal Violet (AC156) 1g, 5g inquiry ASSD-161 Methylene Blue (AC161) 50 mg, 1 g inquiry ASSD-149 D-Luciferin sodium salt (AC149) 10 mg, 50 mg, 100 mg inquiry ASSD-126 Fluorescent H2 antagonist [aminopotentidine] (AC126) 50 μg inquiry ASSD-182 9-(2-Carboxy-2-cyanovinyl)julolidine (AC182) 5 mg inquiry ASSD-218 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) 25 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket